Literature DB >> 33687314

Knowledge of Chinese dentists on HPV, their willingness and barriers to recommend HPV vaccination to patients.

Haoyue Xu1, Kai Song2, Lizheng Qin1, Yi Qu1, Qifang Niu1, Bo Li1, Zhengxue Han1.   

Abstract

Objective: This study aimed to assess the knowledge of Chinese dentists on human papilloma virus (HPV), their willingness and factors prevention them from recommending patients for HPV vaccination, and to identify ways through which dentists can acquire HPV-related knowledge.
Methods: This was a cross-sectional study based on Chinese dentists. The anonymous self-filled questionnaire method was used to collect demographic information of participants, their knowledge of HPV, willingness and barriers to recommending HPV vaccines to patients, and the strategies they can adopt to obtain HPV-related knowledge.
Results: A total of 517 dentists completed the questionnaire, and 89.94% of dentists were willing to recommend HPV vaccination to patients. Participants aged 30-39 years, male dentists and dentist-in-charge had relatively lower knowledge scores than other groups. Besides, participants aged 30-39 years, working in private hospitals, and practicing in Southern China had a lower willingness to recommend HPV vaccination to patients. Recommending HPV vaccination to patients is not within the scope of practicing dentists, and concerns about the safety of the HPV vaccine were found to be the main barriers preventing its recommendation. Notably, 97.87% of dentists were eager to acquire HPV-related knowledge, and agreed for the first time to enroll in relevant educational courses.
Conclusion: Chinese dentists had expressed a strong desire to recommend HPV vaccines to patients, even though their knowledge of HPV was scanty. Therefore, measures to improve their understanding of HPV vaccines and eliminate barriers suppressing their willingness to recommend HPV vaccines are urgently needed.

Entities:  

Keywords:  Chinese dentist; human papilloma virus; human papilloma virus vaccination; oropharyngeal cancer; willingness

Mesh:

Substances:

Year:  2021        PMID: 33687314      PMCID: PMC8475622          DOI: 10.1080/21645515.2021.1885967

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  44 in total

1.  Evaluation of p16 as a surrogate marker for transcriptionally active human papillomavirus status of oropharyngeal squamous cell carcinoma in an eastern Chinese population.

Authors:  Shengming Xu; Bao Sun; Rong Zhou; Chaoji Shi; Yong Han; Jiayi Li; Jingjing Sun; Zhen Tian; Zhiyuan Zhang; Jiang Li
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2019-11-21

2.  Cervical cancer prevention in China: a key to cancer control.

Authors:  Fanghui Zhao; Youlin Qiao
Journal:  Lancet       Date:  2019-03-09       Impact factor: 79.321

3.  Acceptability of vaccination against human papillomavirus among women aged 20 to 45 in rural Hunan Province, China: A cross-sectional study.

Authors:  Si Qin; Jing-Xia Fu; Ming-Zhu Chen; Yan-Ting Meng; Chen Xu; Yang Luo
Journal:  Vaccine       Date:  2020-05-26       Impact factor: 3.641

4.  Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Authors:  Suzanne M Garland; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Diane M Harper; Sepp Leodolter; Grace W K Tang; Daron G Ferris; Marc Steben; Janine Bryan; Frank J Taddeo; Radha Railkar; Mark T Esser; Heather L Sings; Micki Nelson; John Boslego; Carlos Sattler; Eliav Barr; Laura A Koutsky
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

5.  Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers.

Authors:  Anil K Chaturvedi; William F Anderson; Joannie Lortet-Tieulent; Maria Paula Curado; Jacques Ferlay; Silvia Franceschi; Philip S Rosenberg; Freddie Bray; Maura L Gillison
Journal:  J Clin Oncol       Date:  2013-11-18       Impact factor: 44.544

6.  Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe.

Authors:  Susanne Hartwig; Jean Lacau St Guily; Géraldine Dominiak-Felden; Laia Alemany; Silvia de Sanjosé
Journal:  Infect Agent Cancer       Date:  2017-04-11       Impact factor: 2.965

7.  Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population.

Authors:  Zhen Wang; Rong-Hui Xia; Dong-Xia Ye; Jiang Li
Journal:  PLoS One       Date:  2016-10-17       Impact factor: 3.240

8.  Cancer incidence in Germany attributable to human papillomavirus in 2013.

Authors:  Nina Buttmann-Schweiger; Yvonne Deleré; Stefanie J Klug; Klaus Kraywinkel
Journal:  BMC Cancer       Date:  2017-10-16       Impact factor: 4.430

9.  Prevalence of Human Papillomavirus Type-16 in Head and Neck Cancer Among the Chinese Population: A Meta-Analysis.

Authors:  Lanwei Guo; Funa Yang; Yulin Yin; Shuzheng Liu; Peng Li; Xiaojun Zhang; Defeng Chen; Yang Liu; Jian Wang; Kai Wang; Yiming Zhu; Qing Lv; Xiaoyu Wang; Xibin Sun
Journal:  Front Oncol       Date:  2018-12-12       Impact factor: 6.244

10.  Human Papillomavirus-Attributable Cancers - United States, 2012-2016.

Authors:  Virginia Senkomago; S Jane Henley; Cheryll C Thomas; Jacqueline M Mix; Lauri E Markowitz; Mona Saraiya
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-08-23       Impact factor: 17.586

View more
  1 in total

1.  Human Papilloma Virus Vaccination and Oropharyngeal Cancer: Knowledge, Perception and Attitude among Italian Pediatric Dentists.

Authors:  Tiziana Cantile; Stefania Leuci; Andrea Blasi; Noemi Coppola; Roberto Sorrentino; Gianmaria Fabrizio Ferrazzano; Michele Davide Mignogna
Journal:  Int J Environ Res Public Health       Date:  2022-01-11       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.